First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: Primary analysis after ≥ 15 months of follow-up from JAVELIN Merkel 200, a registrational phase 2 trial Meeting Abstract
| Authors: | D'Angelo, S.; Lebbé, C.; Mortier, L.; Brohl, A.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G.; Hassel, J.; Kiecker, F.; Ellers-Lenz, B.; Bajars, M.; Hennessy, M.; Nghiem, P. |
| Abstract Title: | First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: Primary analysis after ≥ 15 months of follow-up from JAVELIN Merkel 200, a registrational phase 2 trial |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 7 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2019-11-01 |
| Start Page: | 282 |
| Language: | English |
| ACCESSION: | WOS:000496473200784 |
| PROVIDER: | wos |
| PMCID: | PMC6833189 |
| PUBMED: | 31694725 |
| DOI: | 10.1186/s40425-019-0763-1 |
| Notes: | Meeting Abstract: P362 -- Source: Wos |
